Showing results (1011-1020 of 4,514) with videos related to
Sort By:
Pageof 452
Future Oncology (London, England)|June 12, 2024
A descriptive analysis of real-world oncology biosimilar use in JapanJoshua A Roth, Makan Rahshenas, Grégoire Nowacki, et al.Future Oncology (London, England)|June 11, 2024
Patient preferences for chronic lymphocytic leukemia treatments: a discrete-choice experimentArliene Ravelo, Kelley Myers, Robyn Brumble, et al.Future Oncology (London, England)|June 11, 2024
Disease landscape of advanced HER2-breast cancer patients by treatment line in three EU countries and USAKerigo Ndirangu, Isabelle Chabot, Katie Lewis, et al.Future Oncology (London, England)|June 11, 2024
Treatment options for biliary tract cancer: unmet needs, new targets and opportunities from both physicians' and patients' perspectivesRachna T Shroff, Melinda BachiniFuture Oncology (London, England)|June 11, 2024
How to find a needle in a haystack: a systematic review on targeting KRAS wild-type pancreatic cancerAntoine Mouawad, Sofia Habib, Marc Boutros, et al.Future Oncology (London, England)|June 11, 2024
OCEANIA: real-world study of ovarian cancer treatment patterns across multiple lines of therapy in Argentina and BrazilClaudia Soares, Gabriela Abreu, Thiago Luiz Nogueira da Silva, et al.Future Oncology (London, England)|June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.Future Oncology (London, England)|June 11, 2024
IMbrave152/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinomaShreya Badhrinarayanan, Christopher Cotter, Huaqi Zhu, et al.Future Oncology (London, England)|November 3, 2023
A predictive nomogram developed and validated for gastric cancer patients with triple-negative tumor markersYitian Xu, Pengshan Zhang, Zai Luo, et al.Future Oncology (London, England)|November 2, 2023
Plain language summary of erdafitinib in locally advanced or metastatic urothelial carcinoma: a phase 2 study with long-term follow-upYohann Loriot, Anne O'Hagan, Arlene O Siefker-RadtkePageof 452